ADM-03820

N/A

Report date: 2024/11/07 13:42:09

Base Information

Drug NameADM-03820
Drug Alias Namea 1:1 mixture of two human IgG1 non-competitive binding anti-SARS-CoV-2 antibodies(Ology Bioservices)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Coronavirus spike glycoprotein
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOlogy Bioservices Inc
China Registration ClassN/A

Develop Information

Active CompaniesResilience Government Services Inc
Inactive CompaniesOlogy Bioservices Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A